Dyskeratosis congenita--two siblings with a new missense mutation in the DKC1 gene

Pediatr Dermatol. 2011 Jul-Aug;28(4):464-6. doi: 10.1111/j.1525-1470.2010.01299.x. Epub 2011 Jul 8.

Abstract

Dyskeratosis congenital is reported in two siblings. They presented with the classic triad of mucocutaneous features: leukoplakia of the tongue, dystrophic nails, and a widespread reticulate pigmentation on the neck and upper chest. A genetic analysis was performed and a new missense mutation S356P, hemizygous, was identified in the DKC1 gene in both patients. Acitretin was started at a low-dose in both patients, resulting in clinical improvement and important, positive psychosocial effects.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / therapeutic use
  • Adolescent
  • Cell Cycle Proteins / genetics*
  • Child
  • Dyskeratosis Congenita / drug therapy
  • Dyskeratosis Congenita / genetics*
  • Female
  • Humans
  • Keratolytic Agents / therapeutic use
  • Male
  • Mutation, Missense*
  • Nuclear Proteins / genetics*
  • Siblings

Substances

  • Cell Cycle Proteins
  • DKC1 protein, human
  • Keratolytic Agents
  • Nuclear Proteins
  • Acitretin